BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26581044)

  • 1. Nitric Oxide-Related Biological Pathways in Patients with Major Depression.
    Baranyi A; Amouzadeh-Ghadikolai O; Rothenhäusler HB; Theokas S; Robier C; Baranyi M; Koppitz M; Reicht G; Hlade P; Meinitzer A
    PLoS One; 2015; 10(11):e0143397. PubMed ID: 26581044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
    Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane.
    Mommersteeg PM; Schoemaker RG; Eisel UL; Garrelds IM; Schalkwijk CG; Kop WJ
    Psychosom Med; 2015 Apr; 77(3):292-302. PubMed ID: 25790241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine levels in thyroid diseases.
    Arikan E; Karadag CH; Guldiken S
    J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
    Krzystek-Korpacka M; Wiśniewski J; Fleszar MG; Bednarz-Misa I; Bronowicka-Szydełko A; Gacka M; Masłowski L; Kędzior K; Witkiewicz W; Gamian A
    Oxid Med Cell Longev; 2019; 2019():5965721. PubMed ID: 31396302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
    Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the L-arginine/L-homoarginine/nitric oxide pathway in preterm neonates: potential roles for homoarginine and asymmetric dimethylarginine in foetal growth.
    Buck A; Kayacelebi AA; Chobanyan-Jürgens K; Illsinger S; Bohnhorst B; Beckmann B; Hanff E; Das AM; Tsikas D; Lücke T
    Amino Acids; 2017 Apr; 49(4):783-794. PubMed ID: 28161799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine and asymmetric dimethylarginine in pregnant women with major depression.
    Raw A; Gallaher M; Powers RW
    Psychosom Med; 2014; 76(6):430-6. PubMed ID: 24979576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G; Umbrello M; Albicini M; Spanu P; Bellani G; Polli F; Pavlovic R; Cugno M; Fermo I; Paroni R
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.
    Weinberg JB; Yeo TW; Mukemba JP; Florence SM; Volkheimer AD; Wang H; Chen Y; Rubach M; Granger DL; Mwaikambo ED; Anstey NM
    J Infect Dis; 2014 Sep; 210(6):913-22. PubMed ID: 24620026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients.
    Reyhani A; Celik Y; Karadag H; Gunduz O; Asil T; Sut N
    Neurol Sci; 2017 Jul; 38(7):1287-1291. PubMed ID: 28455769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
    Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
    Bilgiç Ö; Altınyazar HC; Baran H; Ünlü A
    Arch Dermatol Res; 2015 Jul; 307(5):439-44. PubMed ID: 25708188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
    Paroni R; Barassi A; Ciociola F; Dozio E; Finati E; Fermo I; Ghilardi F; Colpi GM; Corsi MM; Melzi d'Eril GV
    Int J Androl; 2012 Oct; 35(5):660-7. PubMed ID: 22519580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.